Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Shares Outstanding of 43.22 million shares for fiscal year 2025.
Dianthus Therapeutics, Inc. /DE/ Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 43.22M | +38.9% |
| 2024 | 31.12M | +110.0% |
| 2023 | 14.82M | +1592.9% |
| 2022 | 875,279 | -98.5% |
| 2021 | 58.80M | +21.2% |
| 2020 | 48.53M | +23.6% |
| 2019 | 39.26M | +17.9% |
| 2018 | 33.31M | +1316.5% |
| 2017 | 2.35M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 42.85M | +45.9% | +33.2% |
| June 30, 2025 | 32.18M | +9.6% | +0.2% |
| March 31, 2025 | 32.13M | +9.5% | +3.2% |
| December 31, 2024 | 31.12M | +110.0% | +6.0% |
| September 30, 2024 | 29.37M | +98.2% | +0.0% |
| June 30, 2024 | 29.35M | -51.6% | +0.0% |
| March 31, 2024 | 29.35M | -51.6% | +98.1% |
| December 31, 2023 | 14.82M | +1592.9% | -0.0% |
- Dianthus Therapeutics, Inc. /DE/ showed an increase of +38.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Dianthus Therapeutics, Inc. /DE/’s shares outstanding has grown by 1738.3% (from 2.35 million shares to 43.22 million shares).
- The most recent figure is from Dianthus Therapeutics, Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: